Rodger Novak
Director/Board Member en ERS Genomics Ltd. .
Fortuna: 39 M $ al 31/03/2024
Perfil
Rodger Novak fundó CRISPR Therapeutics AG y Nabriva Therapeutics GmbH. En la actualidad, el Dr. Novak ocupa el cargo de Presidente de CRISPR Therapeutics AG. En el pasado, ocupó el cargo de Jefe Global de Investigación y Desarrollo de Antibióticos en Sanofi Pharma SA, Director de Operaciones de Nabriva Therapeutics GmbH, Jefe de Asuntos Científicos y Médicos en el Instituto de Investigación de Antibióticos, Jefe Adjunto del Instituto de Investigación de Antibióticos en Sandoz AG, Jefe Adjunto del Instituto de Investigación de Antibióticos en Sandoz GmbH y Profesor de Microbiología en el Biocentro de Viena. Rodger Novak se doctoró en la Universidad Philipps de Marburgo.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CRISPR THERAPEUTICS AG
0.68% | 31/03/2023 | 573 007 ( 0.68% ) | 39 M $ | 31/03/2024 |
Cargos activos de Rodger Novak
Empresas | Cargo | Inicio |
---|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Private Equity Investor | 01/10/2020 |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Director/Board Member | 01/01/2014 |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Private Equity Investor | 01/10/2020 |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum. | Director/Board Member | - |
Antiguos cargos conocidos de Rodger Novak.
Empresas | Cargo | Fin |
---|---|---|
CRISPR THERAPEUTICS AG | Chief Executive Officer | 01/12/2017 |
Sanofi AG | Corporate Officer/Principal | 01/11/2013 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Corporate Officer/Principal | 01/12/2005 |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Corporate Officer/Principal | - |
Vienna Biocenter
Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Vienna Biocenter is a hub for life sciences with over 29 biotech companies located on campus. The Vienna Biocenter is home to research institutes, including GMI, IMBA, IMP, Max Perutz Labs, Vienna BioCenter Core Facilities, FH Campus Wien, and biotech companies. The non-profit company is based in Vienna, Austria. The Austrian company specializes in vaccines, immunology, and disease diagnostics. | Corporate Officer/Principal | - |
Formación de Rodger Novak.
Philipps University of Marburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Empresas privadas | 10 |
---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Antibiotic Research Institute | Commercial Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Health Technology |
Sanofi AG | |
Vienna Biocenter
Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Vienna Biocenter is a hub for life sciences with over 29 biotech companies located on campus. The Vienna Biocenter is home to research institutes, including GMI, IMBA, IMP, Max Perutz Labs, Vienna BioCenter Core Facilities, FH Campus Wien, and biotech companies. The non-profit company is based in Vienna, Austria. The Austrian company specializes in vaccines, immunology, and disease diagnostics. | Commercial Services |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Finance |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum. | Commercial Services |
- Bolsa de valores
- Insiders
- Rodger Novak